Europe's deeptech 'soonicorns'
These are the deeptech startups across Europe that are the most likely to become unicorns in the near future and hit $1bn valuations.
Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These are the deeptech startups across Europe that are the most likely to become unicorns in the near future and hit $1bn valuations.
EQS-News: France Biotech / Key word(s): Conference The 4th edition of the HealthTech Innovation Days (HTID), in Paris, succeeded in bringing together key players of the European healthtech
Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
Investegate announcements from Mablink Bioscience, Mablink Bioscience announces a 31 million Series A
The financing will enable the company to advance its lead candidate to the clinic and to build a pipeline of next-generation antibody-drug conjugates (ADCs)Its proprietary ADC technology opens the door